Ticker
GYRECompany Name
GYRE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 152.65M | $ 98.01M | 64.21% |
3/31/2025 | $ 129.79M | $ 96.84M | 74.62% |
12/31/2024 | $ 125.41M | $ 101.87M | 81.23% |
9/30/2024 | $ 125.24M | $ 183.99M | 146.91% |
6/30/2024 | $ 120.93M | $ 159.46M | 131.86% |
3/31/2024 | $ 122.01M | $ 135.01M | 110.65% |
12/31/2023 | $ 116.54M | $ 108.81M | 93.37% |
9/30/2023 | $ 9.96M | $ 0 | 0% |
6/30/2023 | $ 12.39M | $ 0 | 0% |
3/31/2023 | $ 18.75M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for GYRE THERAPEUTICS INC is calculated as follows: GP [ $ 11.79M ] / Assets [ $ 111.8M ]
(=) GPA [ 10.54% ]
Minimum
Mar 31, 2021
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.95% |